文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

HIV-1感染者血浆蛋白组免疫抑制特征与巨细胞病毒相关

Plasma Proteome Signature of Immune Inhibition is Associated with Cytomegalovirus in People with HIV-1.
PubMed 文献 · J Infect Dis · 2026-10-07

该研究对59例接受抑制性ART且年龄和CD4计数匹配的HIV-1感染者(CMV阳性或阴性)进行炎症和心血管代谢聚焦的血浆蛋白质组学分析,发现CMV阳性者118/350炎症蛋白和27/363心血管代谢蛋白差异表达,上调蛋白涉及免疫抑制、细胞毒性分化和干扰素相关趋化,下调蛋白涉及凋亡,且CMV阳性者CD57+CD28-CD8 T细胞表面FcRL6表达升高。

要点

  • CMV阳性HIV感染者血浆蛋白组呈现免疫抑制和细胞毒性特征
  • 差异表达蛋白涉及免疫抑制、细胞毒性分化和干扰素趋化
  • CMV阳性者终末分化CD8 T细胞表面FcRL6表达升高

核心结论

  • 在抑制性ART的HIV感染者中,CMV与血浆蛋白组免疫抑制/细胞毒性特征相关,支持靶向CMV以减少免疫失调。

研究设计与样本

  • 研究纳入59例年龄和CD4计数匹配、接受抑制性ART的HIV-1感染者,按CMV阳性或阴性分组,采用炎症和心血管代谢聚焦的邻近延伸分析检测血浆蛋白质组,并用线性混合效应模型、偏最小二乘判别分析和基因集富集分析,流式细胞术评估T细胞表型。

主要发现

  • 在未调整协变量的线性混合效应模型中,118/350(33.7%)炎症蛋白和27/363(7.4%)心血管代谢蛋白差异表达(FDR校正p<0.05)。
  • CMV阳性者中显著上调的蛋白与免疫抑制(如FcRL6、LY9、HLA-DRA)、细胞毒性分化(如KLRD1、CD70、SLAMF7)和干扰素相关趋化(如CXCL9、CXCL10)相关。
  • CMV阳性者中显著下调的蛋白与凋亡相关(如CASP2、TRIM21、TRAF2)。
  • CMV阳性者CD57+CD28-CD8 T细胞表面FcRL6表达显著升高。

临床怎么用

  • 对于接受抑制性ART的HIV感染者,可关注CMV感染状态与免疫抑制/细胞毒性蛋白特征的关系,考虑靶向CMV以减轻免疫失调。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cytomegalovirus (CMV) is highly prevalent and associated with comorbidities in people with HIV-1 (PWH). CMV contributes to systemic inflammation, but comprehensive analyses of the plasma proteome in PWH with or without CMV are lacking. METHODS: Plasma proteomes from 59 age- and CD4 count-matched PWH on suppressive antiretroviral therapy (ART) with (CMV+) or without (CMV-) CMV were characterized by inflammation- and cardiometabolic-focused proteomics proximity extension assays. Normalized protein expression values were analyzed using linear mixed effects models, partial least squares-discriminant analysis, and gene set enrichment analysis. T cell phenotypes were assessed by flow cytometry. RESULTS: In covariate-unadjusted linear mixed effects models, 118/350 (33.7%) inflammatory and 27/363 (7.4%) cardiometabolic proteins were differentially expressed (FDR-adjusted p<0.05). Proteins most significantly upregulated in CMV+ participants were associated with immune inhibition (e.g., FcRL6, LY9, HLA-DRA), cytotoxic differentiation (e.g., KLRD1, CD70, SLAMF7), and interferon-associated chemotaxis (e.g., CXCL9, CXCL10). Several of the most significantly downregulated proteins in CMV+ PWH were associated with apoptosis (e.g., CASP2, TRIM21, TRAF2). Surface FcRL6 expression was significantly elevated on CD57+CD28- CD8 T cells of CMV+ PWH. CONCLUSIONS: These data identify a CMV-associated plasma proteomic signature in treated HIV, characterized by immunoinhibitory/cytotoxic programs, supporting targeting CMV to reduce immune dysregulation and related comorbidities in PWH. We compared protein levels in plasmas of people with HIV, with and without cytomegalovirus (CMV). We found that CMV was associated with a substantial dysregulation of the plasma protein composition, including increased markers of inhibitory or regulatory signaling (including FcRL6), cytotoxic differentiation and activation, and inflammation, and decreased markers of apoptosis. Consistent with increased plasma levels, we found that surface expression of FcRL6 was significantly elevated on terminally differentiated T cells of people with HIV and CMV compared to levels on those cells from people with HIV without CMV. Our findings support targeting CMV to reduce immune dysregulation in people with HIV.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Freeman ML, Honerkamp-Smith G, Wells A, et al. Plasma Proteome Signature of Immune Inhibition is Associated with Cytomegalovirus in People with HIV-1. J Infect Dis. 2026. PMID: 42841799. doi:10.1093/infdis/jiag498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。